SWM
IRWD icon

Selective Wealth Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Selective Wealth Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-173
Closed -$2K – 366
2020
Q2 		$2K Hold
173
– – ﹤0.01% 379
2020
Q1 		$2K Hold
173
– – ﹤0.01% 286
2019
Q4 		$2K Sell
173
-94
-35% -$1.04K ﹤0.01% 289
2019
Q3 		$2K Buy
+267
New +$2.6K ﹤0.01% 294

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Selective Wealth Management's IRWD Position: Q3 2020 in Review

Selective Wealth Management sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2020, closing a stake of 173 shares — an estimated $2K sold.

Selective Wealth Management first reported a position in IRWD in Q3 2019 and held it in 4 quarters. The position peaked at $2K in Q2 2020. 190 funds tracked by Wall St. Rank hold IRWD as of Q3 2020.

  • Selective Wealth Management reported no remaining Ironwood Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Selective Wealth Management sold 173 Ironwood Pharmaceuticals shares in Q3 2020, an estimated $2K.
  • Selective Wealth Management first reported a position in Ironwood Pharmaceuticals in Q3 2019 and held it in 4 quarters.
  • Selective Wealth Management's Ironwood Pharmaceuticals position peaked at $2K in Q2 2020.
  • 190 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2020.

Based on Selective Wealth Management's 13F filing for Q3 2020, filed 21 Oct 2020.